Effects of early insulin therapy on sterol regulatory element binding protein 1 pathway and lipid accumulation in liver of type 2 diabetic rats

National Medical Journal of China

Volumn 91, Issue 26, 2011, Pages 1809-1812

  Sun, Wei Ping ^a   Bi, Yan ^a   Liang, Hua ^a   Cai, Meng Yin ^a   Chen, Xiang ^a   Zhu, Yan Hua ^a   Ye, Jian Ping ^a   Weng, Jian Ping ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Diabete mellitus, type 2; Insulin; Steatosis; Sterol regulatory element binding protein 1

Indexed keywords

INSULIN; LIPID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STREPTOZOCIN; SREBF1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; INSULIN TREATMENT; LIPID DIET; LIPID STORAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; WESTERN BLOTTING; ADIPOSE TISSUE; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; LIPID METABOLISM; LIVER; MALE; METABOLISM; SPRAGUE DAWLEY RAT;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; INSULIN; LIPID METABOLISM; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84870472682     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2011.26.004     Document Type: Article

References (17)

1. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest, 2002, 109: 1125-1131.
2. 2008, 88: 848-852.
3. Anderwald C, Bernroider E, Krssak M, et al. Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes, 2002, 51: 3025-3032.
4. Juurinen L, Tiikkainen M, Hakkinen AM, et al. Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes. Am J Physiol Endocrinol Metab, 2007, 292: E829-E835.
5. Neschen S, Moore I, Regittnig W, et al. Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content. Am J Physiol Endocrinol Metab, 2002, 282: E395-E401.
6. Ji C, Kaplowitz N. ER stress: can the liver cope? J Hepatology, 2006, 45: 321-333.
7. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest, 2004, 114: 147-152.
8. Rawson RB. The SREBP pathway-insights from Insigs and insects. Nat Rev Mol Cell Biol, 2003, 4: 631-640.
9. Ozcan U, Yilmaz E, Ozcan L, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science, 2006, 313: 1137-1140.
10. Takaishi K, Duplomb L, Wang MY, et al. Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted/refed normal rats. Proc Natl Acad Sci U S A, 2004, 101: 7106-7111.
11. Shimomura I, Bashmakov Y, Ikemoto S, et al. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci U S A, 1999, 96: 13656-13661.
12. Hausman GJ, Richardson RL. Adipose tissue angiogenesis. J Anim Sci, 2004, 82: 925-934.
13. Cao Y. Angiogenesis modulates adipogenesis and obesity. J Clin Invest, 2007, 117: 2362-2368.
14. Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond), 2009, 33: 54-66.
15. Ye J, Gao Z, Yin J, et al. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab, 2007, 293: E1118-E1128.
16. Yin J, Gao Z, He Q, et al. Role of hypoxia in obesity-induced disorders of glucose and lipid metabolism in adipose tissue. Am J Physiol Endocrinol Metab, 2009, 296: E333-E342.
17. Chen X, Yu QQ, Zhu YH, et al. Insulin therapy stimulates lipid synthesis and improves endocrine functions of adipocytes in dietary obese C57BL/6 mice. Acta Pharmacol Sin, 2010, 31: 341-346.